ARCHIVES

Drug Slows Tumor Growth In Metastatic Kidney Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 7 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

Disease Oriented Programs Must Be Coordinated: Rabson

October 15, 1976

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012

ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb

January 30, 2009

Other DCT Concepts Approved By Board

February 26, 1988

“NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s

September 20, 1991

NCI Advisors Approve Research Network On Screening

August 6, 2010